Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$709.49 USD

709.49
1,040,013

-1.45 (-0.20%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $709.49 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (59 out of 246)

Industry: Medical - Dental Supplies

Zacks News

Zacks Equity Research

Are Medical Stocks Lagging McKesson (MCK) This Year?

Here is how McKesson (MCK) and DaVita HealthCare (DVA) have performed compared to their sector so far this year.

Zacks Equity Research

DexCom's (DXCM) G6 CGM Connects With Omnipod 5 AID in Germany

DexCom's (DXCM) G6 CGM system and Omnipod 5 AID system can now simplify diabetes management and improve health outcomes in Germany.

Zacks Equity Research

NextGen's (NXGN) Shares Rise on Potential Acquisition Rumors

NextGen (NXGN) and a private equity firm, Thomas Bravo, are in advanced stages of discussion related to the acquisition of the former by the latter.

Zacks Equity Research

Reasons to Add Stryker (SYK) Stock to Your Portfolio Now

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.

Zacks Equity Research

Phibro (PAHC) Q4 Earnings Miss Estimates, Gross Margin Falls

Robust performance across the Animal Health segment is encouraging for Phirbo (PAHC).

Zacks Equity Research

Veeva (VEEV) Rises on Robust Earnings: More Room to Grow?

Veeva (VEEV) reports better-than-expected earnings and revenues for the second quarter. The raised earnings outlook for fiscal 2024 reflects optimism. Will the uptrend in shares continue?

Zacks Equity Research

Cardinal Health's (CAH) Latest Launch to Enhance Neonatal Feeding

Cardinal Health's (CAH) latest offering is likely to help premature and newborn infants develop the oral coordination skills important for the faster transition to independent feeding.

Zacks Equity Research

Veeva Systems (VEEV) Beats on Q2 Earnings, Revises FY24 Outlook

Veeva Systems' (VEEV) fiscal Q2 results reflect impressive performances by both segments.

Zacks Equity Research

Cooper Companies (COO) Q3 Earnings In Line, '23 Outlook Raised

Cooper Companies' (COO) third-quarter fiscal 2023 revenues reflect a solid segmental performance with improved adjusted earnings amid rising expenses.

Zacks Equity Research

Patterson Companies (PDCO) Q1 Earnings In Line, Sales Hurt by FX

Patterson Companies' (PDCO) first-quarter fiscal 2024 results reflect robust improvement in Dental Equipment sales, value-added services and Animal Health segment.

Zacks Equity Research

Catalent (CTLT) Gains Post Deal With Elliott and Earnings Report

Catalent's (CTLT) deal with Elliott and earnings report boost its shares. The company will likely improve its value and growth with the agreement and its strategic investments.

Zacks Equity Research

Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio

Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.

Zacks Equity Research

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

Zacks Equity Research

Zacks.com featured highlights include Sprouts Farmers Market, Molina Healthcare, Atmos Energy and McKesson

Sprouts Farmers Market, Molina Healthcare, Atmos Energy and McKesson are part of the Zacks Screen of the Week article.

Zacks Equity Research

Catalent (CTLT) Preliminary Q4 Revenues Dampened by Lower Sales

Catalent (CTLT) records lower revenues in Biologics segment in its fourth-quarter fiscal 2023, resulting in overall soft preliminary performance.

Zacks Equity Research

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Sumit Singh headshot

Bet on These 4 Stocks With Exciting Interest Coverage Ratio

A company capable of generating earnings well above its interest expense can withstand financial hardship. SFM, MOH, ATO and MCK are strong enough to meet financial obligations.

Zacks Equity Research

Reasons to Retain OPKO Health (OPK) Stock in Your Portfolio

OPKO Health's (OPK) potential in RAYALDEE raises optimism about the stock.

Zacks Equity Research

NextGen (NXGN) to Offer AI-Based Patient Engagement Solutions

NextGen (NXGN), in alliance with Luma Health, is set to offer AI-enhanced solutions for patient communications to ambulatory organizations nationwide.

Zacks Equity Research

Masimo's (MASI) Stork Baby Monitor Now Available Across U.S.

The latest U.S. availability of Masimo's (MASI) Stork smart home baby monitoring system is likely to provide a continuous and accurate view of babies' health data.

Ritujay Ghosh headshot

5 Defensive Stocks to Buy Amid Lingering Market Volatility

Volatility has gripped Wall Street again. So, investing in defensive stocks like McKesson Corporation (MCK), Entergy Corporation (ETR), PepsiCo, Inc. (PEP), Johnson & Johnson (JNJ) and Atmos Energy Corporation (ATO) is a safe bet.

Zacks Equity Research

Here's Why You Should Retain CONMED (CNMD) Stock for Now

CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.

Zacks Equity Research

Fresenius Medical's (FMS) New HHD Device to Increase Portability

Fresenius Medical (FMS) gets FDA clearance for Versi HD with GuideMe Software, a portable, home hemodialysis device with an easy-to-use graphical interface providing easier training experiences.

Zacks Equity Research

NextGen (NXGN) Behavioral Health Suite to Address Mental Health

NextGen's (NXGN) Behavioral Health Suite is expected to ease state reporting and enable the secure sharing of patient information across providers.

Zacks Equity Research

Should Value Investors Buy McKesson (MCK) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.